The World Health Organization (WHO) hadmentioned that the India - made Truenat MTB, a molecular diagnostic test for pulmonary and extrapulmonary TB and rifampicin-resistant TB, has high accuracy. Truenat MTB has “high diagnostic accuracy as initial test to diagnose TB and to sequentially detect rifampicin resistance”. It will be used as an initial test thus replacing sputum smear microscopy. Truenat is developed by the Goa-based Molbio Diagnostics. The company was provided with technical assistance and resources by the Foundation for Innovative New Diagnostics (FIND) to help commercialise Truenat. ICMR had assessed and validated the diagnostic tool.
